A study in the Journal of the American College of Cardiology showed that individuals who had a genetic mutation in the gut that reduced SGLT1 function were at a lower risk of developing type 2 diabetes, as well as a lower risk of heart failure, obesity and mortality. Researchers evaluated data from 8,478 participants and found those with the genetic mutation also had a reduced glucose uptake, compared with those without the mutation.
Study links SGLT1 genetic mutation to reduced diabetes risk
Sign up for DiabetesPro SmartBrief
News for diabetes health professionals
Get the intelligence you need: news and information that is changing your industry today, hand-curated by our professional editors from thousands of sources and delivered straight to your inbox.